Home

Liminatus Pharma, Inc. - Class A Common Stock (LIMN)

8.7200
+0.2500 (2.95%)
NASDAQ · Last Trade: Jul 25th, 4:08 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies
Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed
By Liminatus Pharma Inc. · Via GlobeNewswire · July 25, 2025
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths
By Liminatus Pharma Inc. · Via GlobeNewswire · July 24, 2025
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation
By Liminatus Pharma Inc. · Via GlobeNewswire · July 22, 2025
Power Metallic (TSX.V: PNPN) (OTCQB: PNPNF) Strikes Big at Lion Zone – Major Discovery Near Nisk Ignites Investor Buzz – More Stocks Inside
Power Metallic Mines Inc. (TSX.V: PNPN) (OTCQB: PNPNF) has announced high-grade results from its Winter 2025 drill program, including a standout intercept of 12.54 meters at 10.99% CuEq from hole PML-25-012a at the Lion Zone . The interval includes 3.10 g/t gold, 25.52 g/t silver, 4.09% copper, 12.06 g/t palladium, and 2.00 g/t platinum.
Via AB Newswire · June 5, 2025